Table 2.
Multivariate analysis for progression-free survival and overall survival
| Progression-free survival | ||||
|---|---|---|---|---|
| Factor | HR | 95% C.I. | P | |
| Mobilization | 0.93 | |||
| GF | 1.00 | |||
| CC+GF | 0.99 | 0.84–1.18 | ||
| Karnofsky score, % | 0.004 | |||
| ≥90 | 1.00 | |||
| <90 | 1.21 | 1.01–1.45 | 0.04 | |
| Missing | 1.61 | 1.18–2.20 | 0.003 | |
| Stage at diagnosis (ISS or DSS) | 0.046 | |||
| III | 1.00 | |||
| I or II | 0.80 | 0.67–0.96 | 0.01 | |
| Unknown | 0.93 | 0.64–1.36 | 0.71 | |
| Overall Survival | ||||
| Factor | HR | 95% C.I. | P | |
| Mobilization | 0.27 | |||
| GF | 1.00 | |||
| CC+GF | 1.16 | 0.89–1.52 | ||
| Isotype | 0.01 | |||
| IgG/IgA/Others | 1.00 | |||
| Light chain/Non-secretory | 0.62 | 0.43–0.88 | 0.009 | |
| Unknown | 0.21 | 0.03–1.50 | 0.12 | |
| Stage at diagnosis (ISS or DSS) | <0.001 | |||
| III | 1.00 | |||
| I or II | 0.54 | 0.41–0.71 | <0.001 | |
| Unknown | 0.51 | 0.26–0.97 | 0.04 | |
| HCT-CI | 0.01 | |||
| 0–2 | 1.00 | |||
| >2 | 1.48 | 1.09–2.03 | 0.01 | |